New Key Statistics Module, Z-Score and F-Score
OTCPK:BPMUF Key Ratios
| Market Cap $ M | 649.93 |
| Enterprise Value $ M | 711.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 15.13 |
| Price/Book | 32.67 |
| Price/Sales | 3.91 |
| Price/Free Cash Flow | 79.25 |
| Price/Owner Earnings | 103.08 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 169.00 |
| EPS (TTM) $ | -0.27 |
| Beneish M-Score | -3.03 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -109.20 |
| EV-to-EBIT | -97.15 |
| EV-to-EBITDA | -132.76 |
| PEG | -- |
| Shares Outstanding M | 12.12 |
| Net Margin (%) | -0.44 |
| Operating Margin % | -4.60 |
| Pre-tax Margin (%) | -9.45 |
| Quick Ratio | 3.27 |
| Current Ratio | 4.10 |
| ROA % (ttm) | -0.33 |
| ROE % (ttm) | -8.98 |
| ROIC % (ttm) | -0.26 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.24 |
BPMUF Number of Guru Trades
BPMUF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BPMUF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BPMUF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Basilea Pharmaceutica Ltd Insider Transactions
No Available Data
News about OTCPK:BPMUF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers